Model-based comorbidity clusters in patients with heart failure: association with clinical outcomes and healthcare utilization
File(s)s12916-020-01881-7.pdf (1.34 MB)
Published version
Author(s)
Gulea, Claudia
Zakeri, Rosita
Quint, Jennifer K
Type
Journal Article
Abstract
Background: Comorbidities affect outcomes in heart failure (HF), but are not reflected in current HF classification. The aim of this study is to characterize HF groups that account for higher-order interactions between comorbidities and to investigate the association between comorbidity groups and outcomes.
Methods: Latent class analysis [LCA] was performed on 12 comorbidities from patients with HF identified from administrative claims data in the United States (OptumLabs Data Warehouse®) between 2008-2018. Associations with admission to hospital and mortality were assessed with Cox regression. Negative binomial regression was used to examine rates of healthcare use.
Results: In a population of 318,384 individuals, we identified five comorbidity clusters, named according to their dominant features: low-burden, metabolic-vascular, anemic, ischemic and metabolic. Compared to the low-burden group (minimal comorbidities), patients in the metabolic-vascular group (exhibiting a pattern of diabetes, obesity and vascular disease) had the worst prognosis for admission (HR: 2.21, 95%CI 2.17-2.25) and death (HR: 1.87, 95%CI 1.74-2.01), followed by the ischemic, anemic and metabolic groups. The anemic group experienced an intermediate risk of admission (HR: 1.49, 95%CI 1.44-1.54) and death (HR: 1.46, 95%CI 1.30-1.64). Healthcare use also varied: the anemic group had the highest rate of outpatient visits, compared to the low-burden group (IRR: 2.11, 95%CI, 2.06-2.16); the metabolic-vascular and ischemic groups had the highest rate of admissions (IRR 2.11, 95%CI 2.08-2.15 and 2.11, 95%CI 2.07-2.15) and healthcare costs.
Conclusions: These data demonstrate the feasibility of using LCA to classify HF based on comorbidities alone and should encourage investigation of multidimensional approaches in comorbidity management to reduce admission and mortality risk among patients with HF.
Methods: Latent class analysis [LCA] was performed on 12 comorbidities from patients with HF identified from administrative claims data in the United States (OptumLabs Data Warehouse®) between 2008-2018. Associations with admission to hospital and mortality were assessed with Cox regression. Negative binomial regression was used to examine rates of healthcare use.
Results: In a population of 318,384 individuals, we identified five comorbidity clusters, named according to their dominant features: low-burden, metabolic-vascular, anemic, ischemic and metabolic. Compared to the low-burden group (minimal comorbidities), patients in the metabolic-vascular group (exhibiting a pattern of diabetes, obesity and vascular disease) had the worst prognosis for admission (HR: 2.21, 95%CI 2.17-2.25) and death (HR: 1.87, 95%CI 1.74-2.01), followed by the ischemic, anemic and metabolic groups. The anemic group experienced an intermediate risk of admission (HR: 1.49, 95%CI 1.44-1.54) and death (HR: 1.46, 95%CI 1.30-1.64). Healthcare use also varied: the anemic group had the highest rate of outpatient visits, compared to the low-burden group (IRR: 2.11, 95%CI, 2.06-2.16); the metabolic-vascular and ischemic groups had the highest rate of admissions (IRR 2.11, 95%CI 2.08-2.15 and 2.11, 95%CI 2.07-2.15) and healthcare costs.
Conclusions: These data demonstrate the feasibility of using LCA to classify HF based on comorbidities alone and should encourage investigation of multidimensional approaches in comorbidity management to reduce admission and mortality risk among patients with HF.
Date Issued
2021-01-18
Date Acceptance
2020-12-07
Citation
BMC Medicine, 2021, 19 (9), pp.1-13
ISSN
1741-7015
Publisher
BioMed Central
Start Page
1
End Page
13
Journal / Book Title
BMC Medicine
Volume
19
Issue
9
Copyright Statement
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
License URL
Sponsor
National Heart & Lung Institute Foundation
Identifier
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01881-7
Grant Number
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
Comorbidity
Hospitalization
Mortality
Resource use
Comorbidity
Hospitalization
Mortality
Resource use
11 Medical and Health Sciences
General & Internal Medicine
Publication Status
Published
Date Publish Online
2021-01-18